These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene. Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2. Wahab NA; Weston BS; Mason RM Exp Cell Res; 2005 Jul; 307(2):305-14. PubMed ID: 15950619 [TBL] [Abstract][Full Text] [Related]
5. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis. Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300 [TBL] [Abstract][Full Text] [Related]
6. SIP1 (Smad interacting protein 1) and deltaEF1 (delta-crystallin enhancer binding factor) are structurally similar transcriptional repressors. van Grunsven LA; Schellens A; Huylebroeck D; Verschueren K J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S40-7. PubMed ID: 11263664 [TBL] [Abstract][Full Text] [Related]
7. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFbeta signaling. Stopa M; Benes V; Ansorge W; Gressner AM; Dooley S Mamm Genome; 2000 Feb; 11(2):169-76. PubMed ID: 10656934 [TBL] [Abstract][Full Text] [Related]
8. TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu. Bender H; Wang Z; Schuster N; Krieglstein K J Neurosci Res; 2004 Feb; 75(3):344-52. PubMed ID: 14743447 [TBL] [Abstract][Full Text] [Related]
9. Possible role of TIEG1 as a feedback regulator of myostatin and TGF-beta in myoblasts. Miyake M; Hayashi S; Iwasaki S; Chao G; Takahashi H; Watanabe K; Ohwada S; Aso H; Yamaguchi T Biochem Biophys Res Commun; 2010 Mar; 393(4):762-6. PubMed ID: 20171187 [TBL] [Abstract][Full Text] [Related]
10. On and off: proteasome and TGF-beta signaling. Zhang F; Laiho M Exp Cell Res; 2003 Dec; 291(2):275-81. PubMed ID: 14644150 [TBL] [Abstract][Full Text] [Related]
11. Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells. Jiang L; Lai YK; Zhang JF; Chan CY; Lu G; Lin MC; He ML; Li JC; Kung HF World J Gastroenterol; 2012 May; 18(17):2035-42. PubMed ID: 22563190 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of transforming growth factor beta signaling and Smad-dependent activation of transcription by the Latent Membrane Protein 1 of Epstein-Barr virus. Prokova V; Mosialos G; Kardassis D J Biol Chem; 2002 Mar; 277(11):9342-50. PubMed ID: 11781310 [TBL] [Abstract][Full Text] [Related]
13. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193 [TBL] [Abstract][Full Text] [Related]
14. Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-beta signaling by Smad7. Tajima Y; Goto K; Yoshida M; Shinomiya K; Sekimoto T; Yoneda Y; Miyazono K; Imamura T J Biol Chem; 2003 Mar; 278(12):10716-21. PubMed ID: 12519765 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. Dooley S; Delvoux B; Streckert M; Bonzel L; Stopa M; ten Dijke P; Gressner AM FEBS Lett; 2001 Jul; 502(1-2):4-10. PubMed ID: 11478938 [TBL] [Abstract][Full Text] [Related]
17. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Xu J; Attisano L Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087 [TBL] [Abstract][Full Text] [Related]
19. Role of TIEG1 in biological processes and disease states. Subramaniam M; Hawse JR; Johnsen SA; Spelsberg TC J Cell Biochem; 2007 Oct; 102(3):539-48. PubMed ID: 17729309 [TBL] [Abstract][Full Text] [Related]
20. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]